XPRIZE Healthspan finalists and milestone awardees are advancing to coordinated clinical trials; this article previews the competition’s clinical-phase plans and approach.
Key Takeaways
- XPRIZE Healthspan advanced 20 finalists to coordinated human trials focused on functional improvements
- Ten teams received $1 million milestone awards to support clinical readiness and access to testing resources
- Trials from 2026–2029 will target restorations in muscle, cognitive, and immune function within one year